Understanding Parkinson's Disease: A Comprehensive Overview for Healthcare Professionals
OthersPage Navigation
Understanding Parkinson's Disease: A Comprehensive Overview for Healthcare Professionals
Parkinson's disease (PD) is a progressive neurological disorder that primarily affects movement. It is associated with the degeneration of dopaminergic neurons in the substantia nigra, a part of the brain that controls movement.
Etiology and Pathophysiology
The exact cause of PD is unknown; however, it is thought to involve both genetic and environmental factors. The characteristic pathological feature of PD is the presence of Lewy bodies, protein clumps primarily composed of alpha-synuclein, in the brain.
Clinical Presentation
PD typically presents with motor symptoms such as bradykinesia, rigidity, and resting tremor. Non-motor symptoms, including autonomic dysfunction, cognitive impairment, and mood disorders, are also common.
Diagnosis
Diagnosis of PD is based on clinical criteria. Neuroimaging, such as DAT-SPECT, can support the diagnosis but is not required. The UK Brain Bank criteria are commonly used for diagnosis.
Treatment
There is currently no cure for PD. Treatment is symptomatic and often involves medications to increase or substitute for dopamine. Deep brain stimulation is an option for advanced disease.
Prognosis
The progression of PD varies among individuals. Factors such as age at onset, presence of cognitive impairment, and severity of motor symptoms can influence the prognosis.
Conclusion
Understanding the pathophysiology, clinical presentation, diagnosis, and treatment of PD is crucial for healthcare professionals. Ongoing research aims to better understand the disease and develop more effective treatments. Prompt recognition and appropriate management can significantly improve the quality of life of individuals with PD.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge